We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-2.44%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$308M
AUM Growth
-$109M
Cap. Flow
-$101M
Cap. Flow %
-32.88%
Top 10 Hldgs %
27.78%
Holding
155
New
31
Increased
75
Reduced
13
Closed
36

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.3M
2
DLTR icon
Dollar Tree
DLTR
+$5.02M
3
IMMR icon
Immersion
IMMR
+$4.97M
4
MCK icon
McKesson
MCK
+$4.21M
5
BPOP icon
Popular Inc
BPOP
+$3.58M

Sector Composition

Rank Sector Weight
1 Financials 14.96%
2 Consumer Discretionary 13.29%
3 Materials 11.69%
4 Industrials 11.21%
5 Healthcare 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNTK icon
1
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2B
$13.4M 4.34%
148,100
-9,600
-6% -$1.54M
HRB icon
2
H&R Block
HRB
$5.72B
$9.8M 3.18%
391,933
+37,170
+10% +$926K
LRN icon
3
Stride
LRN
$4.04B
$8.96M 2.91%
249,203
-29,868
-11% -$980K
GTS
4
DELISTED
Triple-S Management Corporation
GTS
$8.6M 2.79%
243,208
+15,595
+7% +$445K
CIVI
5
DELISTED
Civitas Resources
CIVI
$8.36M 2.71%
174,603
+9,322
+6% +$382K
KOP icon
6
Koppers
KOP
$969M
$8.17M 2.65%
261,302
+71,438
+38% +$2.22M
RGA icon
7
Reinsurance Group of America
RGA
$15.9B
$7.73M 2.51%
69,480
+24,182
+53% +$2.75M
BPOP icon
8
Popular Inc
BPOP
$11B
$7.08M 2.3%
91,140
+48,062
+112% +$3.58M
AAPL icon
9
PUT
Apple
AAPL
$4.97T
$7.08M 2.3%
+50,000
New +$7.36M
IMMR icon
10
Immersion
IMMR
$254M
$6.46M 2.1%
944,269
+665,705
+239% +$4.97M
KGC icon
11
Kinross Gold
KGC
$28B
$6.28M 2.04%
1,170,882
+74,539
+7% +$446K
CAH icon
12
Cardinal Health
CAH
$54.5B
$6.03M 1.96%
121,999
+33,920
+39% +$1.84M
PRU icon
13
Prudential Financial
PRU
$43B
$5.92M 1.92%
56,278
+689
+1% +$71K
WKC icon
14
World Kinect Corp
WKC
$2.06B
$5.8M 1.88%
172,634
+19,950
+13% +$639K
FBP icon
15
First Bancorp
FBP
$4.44B
$5.73M 1.86%
435,892
+68,895
+19% +$848K
MG icon
16
Mistras Group
MG
$489M
$5.67M 1.84%
558,099
+49,988
+10% +$493K
TROX icon
17
Tronox
TROX
$997M
$5.54M 1.8%
224,951
+143,409
+176% +$2.95M
HRB icon
18
CALL
H&R Block
HRB
$5.72B
$5M 1.62%
200,000
-25,000
-11% -$623K
DLTR icon
19
Dollar Tree
DLTR
$24.5B
$5M 1.62%
+52,215
New +$5.02M
TBI
20
Trueblue
TBI
$237M
$4.84M 1.57%
178,903
+76,565
+75% +$2.05M
TZOO icon
21
Travelzoo
TZOO
$78.8M
$4.84M 1.57%
417,348
+51,024
+14% +$648K
CLS icon
22
Celestica
CLS
$39.4B
$4.76M 1.55%
536,395
+48,384
+10% +$415K
BABA icon
23
Alibaba
BABA
$277B
$4.31M 1.4%
+29,138
New +$5.3M
MCK icon
24
McKesson
MCK
$104B
$4.2M 1.36%
+21,068
New +$4.21M
CNC icon
25
Centene
CNC
$31.7B
$4.16M 1.35%
66,802
+9,469
+17% +$633K

Similar funds

Invenomic Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Invenomic Capital Management held 155 positions worth $308M, down 26% from $418M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Invenomic Capital Management withdrew a net $101M in Q3 2021, closing 36 positions and reducing 13 holdings. Its most notable exit was Lockheed Martin, an estimated $3.38M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 9.1% a quarter earlier, followed by Consumer Discretionary and Materials.

Against the trend, Invenomic Capital Management opened a new position in Alibaba worth $4.31M.

  • Invenomic Capital Management's largest Q3 2021 buy was Alibaba: 29,138 shares worth $4.31M.
  • Invenomic Capital Management added most to Immersion in Q3 2021, an estimated $4.97M increase.
  • Invenomic Capital Management's biggest Q3 2021 reduction was Teck Resources, cutting an estimated $3.41M.
  • Invenomic Capital Management fully exited Lockheed Martin in Q3 2021, selling an estimated $3.38M.
  • Invenomic Capital Management's ten largest holdings make up 28% of its $308M portfolio in Q3 2021.
  • Invenomic Capital Management opened 31 new positions and closed 36 in Q3 2021.
  • Invenomic Capital Management's portfolio value fell 26% quarter-over-quarter to $308M.

Based on Invenomic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.